Press Releases
Against the SARS-CoV-2 BA.1 and BA.2 Omicron Variants Safety and Immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA Third Booster Vaccine Dose
A recent article reported that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) booster vaccinations...
Against the Omicron Variant of SARS-CoV-2 Study Finds Curcumin is a Potential Therapeutic Agent
A recent study published demonstrated that the phytochemical curcumin is a potent therapeutic prospect against...
Through CAR-T Like Bispecific T Cell Engagers Incorporating ACE2 Targeting SARS-CoV-2 Infection
A number of therapeutic approaches have been considered against the severe acute respiratory syndrome coronavirus...
All SARS-CoV-2 Variants of Concern Potently Neutralizes by Bebtelovimab
New variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to emerge, posing formidable...
The Diversity of the Gut Microbiome Affected because of SARS-CoV-2 Infection
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily infects epithelial lung cells, but it has...
Impact of Booster Vaccination Campaign in Israel Related to SARS-CoV-2
In a recent study, researchers assess the implications of the coronavirus disease 2019 (COVID-19) booster...
Impact and Role of cGAS-STING in SARS-CoV-2 Infection
Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that led to the coronavirus...
Strong but Incomplete Immune Escape of the SARS-CoV-2 Omicron Variant Revealed via Analysis of mRNA Vaccination-Elicited RBD-Specific Memory B Cells
In the recent paper, researchers have shown how the Omicron (B.1.1.529) variant of the severe...
After Delta CDC Report on Omicron Infections
A case series published in Centers for Disease Control and Prevention (CDC) Morbidity and Mortality...
Comparison of SARS-CoV-2 Delta and Omicron Waves in Germany
In a recent study, researchers compared the outcomes and characteristics of hospitalized severe acute respiratory...